期刊文献+

Raf激酶抑制蛋白、NF-κBp65及VEGF-C在卵巢上皮性肿瘤中的表达及相关性 被引量:6

Expression of Raf kinase inhibitory protein,NF-κBp65 and VEGF-C in epithelial ovarian tumors and their association with clinical features
原文传递
导出
摘要 目的探讨Raf激酶抑制蛋白(RKIP)、NF-κBp65和血管内皮生长因子(VEGF)-C在上皮性卵巢肿瘤发生、发展中的作用和可能的分子机制。方法以免疫组织化学SP法检测手术切除卵巢标本中正常卵巢组织(20例)、卵巢良性上皮性肿瘤(18例)、交界性肿瘤(17例)、上皮性卵巢癌组织(32例)中RKIP、NF-κBp65和VEGF-C蛋白的表达,分析各组间这三者表达的变化与临床、病理因素之间的关系,以及三者间的相关性。结果 (1)与正常卵巢组织和卵巢良性上皮性肿瘤组织比较,上皮性卵巢癌组织中RKIP的表达阳性率(28.13%vs90.00%,p<0.01;28.13%vs55.56%,P<0.05)显著降低;NF-κBp65蛋白的表达阳性率(81.25%vs15.00%P<0.01;81.25%vs50.00%,P<0.05)显著增高;VEGF-C的表达阳性率(90.63%vs40.00%,P<0.01;90.63%vs44.44%,P<0.01)显著增高。(2)上皮性卵巢癌中RKIP、NF-κBp65的表达与患者年龄、组织学类型及病理分级无相关性(P均>0.05),与临床分期有相关性(P<0.05);VEGF-C的表达与患者年龄、组织学类型、病理分级及临床分期无关(P均>0.05)。(3)上皮性卵巢癌组织中RKIP与NF-κBp65的表达呈负相关(r=-0.4338,P=0.0131)。结论 RKIP、NF-κBp65和VEGF-C可能参与上皮性卵巢癌的发生与发展,RKIP可能通过调控NF-κB信号通路在上皮性卵巢癌的侵袭与转移中发挥作用。 Objective To explore the function of Raf kinase inhibitory protein (RKIP), NF-KBp65 and VEGF-C protein in epithelial ovarian tumors occurrence and development as well as the possible molecular mechanisms. Methods We detected the expression of RKIP, NF-KBp65 and VEGF-C protein in normal ovarian tissues(20 cases), Ovarian benign epithelial tumors( 18 cases), borderline ovarian tumors( 17 cases) and epithelial ovarian cancers(32 cases) by SP immunohistochemical assay, and analyzed the expression changes of RKIP, NF- KBp65 and VEGF-C between different groups, as well as the relationship between RKIP, NF-KBp65 and VEGF-C protein expression with clinical and pathological factors. The correlations among the three proteins were also analyzed. Results ( 1 ) RKIP expression positive rate in epithelial ovarian cancer tissues is 28. 13%, which is significantly lower than it in the normal ovarian tissues and benign ovarian epithelial tumor tissues (P 〈 0.01, P 〈 0.05 ). NF-KBp65 protein expression positive rate in epithelial ovarian cancer tissue is 81. 25%, which is significantly higher than it in the normal ovarian tissue and ovarian benign epithelial tumor tissue (P 〈 0.01, P 〈 0.05 ). VEGF-C expression positive rate in epithelial ovarian cancer tissue is 90.63%, which is significantly higher than it in the normal ovarian tissue and benign ovarian epithelial tumor tissue ( P 〈 O. 01, P 〈 O. 01 ). ( 2 ) The expression of RKIP and NF-KBp65 in epithelial ovarian cancer has no correlation with the patients' age, histological type and pathological grade, but has correlation with the clinical stages ( P 〈 0. 05 ) ; The VEGF-C expression has no correlation with the patients' age, histological type, histological grade and clinical stages. (3)The expression of RKIP and NF-KBp65 in Epithelial ovarian cancer tissues is negatively correlated (r = -0. 4338, P = 0. 0131 ). Conclusions RKIP, NF-KBp65 and VEGF-C may be involved in the occurrence and development of epithelial ovarian cancer. The RKIP play a role in the invasion and metastasis of epithelial ovarian cancer possibly through regulation of NF-KB signal pathway.
出处 《中国临床研究》 CAS 2013年第6期525-527,530,共4页 Chinese Journal of Clinical Research
关键词 上皮性卵巢癌 Raf激酶抑制蛋白(RKIP) 核因子(NF)-κBp65 血管内皮生长因子(VEGF)-C Epithelial ovarian cancer Raf kinase inhibitory protein NF-KBp65 Vascular endothelial growthfactor-C
  • 相关文献

参考文献9

  • 1Gilmore TD. Introduction to NF-κB: players, pathways, perspec- tives [ J ]. Oncogene, 2006,25 (51 ) : 6680 - 6684.
  • 2Yeung K, Janosch P, McFerran B, et al. Mechanism of suppres- sion of the Raf/MEK/extracellular sigual-regulated kinase pathway by the raf kinase inhibitor protein [ J ]. Mol Cell Biol, 2000,20 (9) :3079 - 3085.
  • 3Schiffenbaner YS, Meir G, blaoz M, et al. Gonadutropin stimula- tion of MLS human epithelial ovarian carcinoma cells augments cell adhesion mediated by CD44 and by alpha( v)-integrin[J]. Gyne- col Oncol ,2002, 84 (2) :296 -302.
  • 4Edmondson R J, Monaghan JM, Davies BR. The human ovarian surface epithelium is an androgen responsive tissue[ J]. Br J Canc- er,2002,86 ( 6 ) : 879 - 885. B.
  • 5onome T, Lee JY, Park DC, et al. Expression profiling of serous low malignant potential, low-grade, and high-grade tumors of the o- vary[J]. Cancer Res, 2005, 65(22) :10602 -10612.
  • 6Wang J, Luo F, Lu JJ,et al. VEGF expression and enhanced pro- duction by gonadotrepins in ovarian epithelial tumors [ J ]. Int J Cancer,2002,97(2) :163 - 167.
  • 7Wang J, Mahmud SA, Bittennan PB, et al. Histone deacetylase in- hibitors suppress TF-kappaB-dependent agonist-driven tissue factor expression inendothelial cells and monocytes [ J ]. J Bi01 Chem, 2007, 282(39) :28408 -28418.
  • 8王梅,郭钰珍,闫爱琴,李瑞萍,张正梅.卵巢上皮性癌中Raf激酶抑制蛋白、核因子κBp65蛋白的表达及相关性研究[J].实用妇产科杂志,2011,27(4):276-280. 被引量:8
  • 9王海杰,谭玉珍.淋巴管新生及其在相关疾病发生和治疗中的意义[J].解剖学报,2007,38(2):250-252. 被引量:21

二级参考文献42

共引文献27

同被引文献48

  • 1许良中,杨文涛.免疫组织化学反应结果的判断标准[J].中国癌症杂志,1996,6(4):229-231. 被引量:1379
  • 2董佑红,伍钢,王涛,刘莉.NF-κB p50和VEGF在弥漫性大B细胞淋巴瘤组织中的表达及其临床意义[J].中华肿瘤防治杂志,2007,14(6):436-439. 被引量:12
  • 3Davoudi Z,Akbarzadeh A,Rahmatiyamchi M,et al.Molecular Target Therapy of AKT and NF-κB Signaling Pathways and Multidrug Resistance by Specific Cell Penetrating Inhibitor Peptides in HL-60Cells[J].Asian Pac J Cancer Prev,2014,15(10):4353-4358.
  • 4Xu Y,Kong X,Zhou H,et al.oxLDL/β2GPI/anti-β2GPI complex induced macrophage differentiation to foam cell involving TLR4/NF-kappa B signal transduction pathway[J].Thromb Res,2014,5(20):3842-3848.
  • 5Zhao Y,Wang CL,Li RM,et al.Wnt5a Promotes Inflammatory Responses Via Nuclear Factor kB(NF-κB)and Mitogen-activated Protein Kinase(MAPK)Pathways in Human Dental Pulp Cells[J].J Biol Chem,2014,6(2):466-470.
  • 6Chuang YW,Chang WM,Chen KH,et al.Lysophosphatidic Acid Enhanced the Angiogenic Capability of Human Chondrocytes by Regulating Gi/NF-κB-Dependent Angiogenic Factor Expression[J].PLoS One,2014,9(5):95180-95185.
  • 7Li J,Yan M,Wang Z,et al.Effects of Canonical NF-κB Signaling Pathway on the Proliferation and Odonto/Osteogenic Differentiation of Human Stem Cells from Apical Papilla[J].Biomed Res Int,2014,20(4):3196-3200.
  • 8Jegaskanda S,Ahn SH,Skinner N,et al.Down-regulation of IL-18mediated cell signalling and IFN-γexpression by the hepatitis B virus e antigen[J].J Virol,2014,5(28):3556-3560.
  • 9Yogurtcu B, Hatemi I, Aydin I, et al. NPRL2 gene expression in the progression of colon tumors [ J ]. Genet Mol Res, 2012, 11 ( 4 ) : 4810-4816.
  • 10Gao Y, Wang J, Fan G. NPRL2 is an independent prognostic factor of osteosarcoma [ J ]. Cancer Biomark,2013,12 ( 1 ) :31-36.

引证文献6

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部